Literature DB >> 12668789

Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD.

W A Biernacki1, S A Kharitonov, P J Barnes.   

Abstract

BACKGROUND: Exacerbations are an important feature of chronic obstructive pulmonary disease (COPD), accounting for a large proportion of health care costs. They are associated with increased airway inflammation and oxidative stress.
METHODS: Concentrations of leukotriene B4 (LTB4), a marker of inflammation, and 8-isoprostane, a marker of oxidative stress, were measured in the exhaled breath condensate of 21 patients (11 M) with COPD during an exacerbation and 2 weeks after treatment with antibiotics. In 12 patients who had no further exacerbations these markers were also measured after 2 months.
RESULTS: LTB4 concentrations were raised during the COPD exacerbation (mean (SE) 15.8 (1.1) pg/ml and fell after treatment with antibiotics to 9.9 (0.9) pg/ml (p<0.0001). In 12 patients the level of LTB4 fell further from 10.6 (1.1) pg/ml to 8.5 (0.8) pg/ml (p<0.005) after 2 months. In 12 normal age matched subjects the LTB4 levels were 7.7 (0.5) pg/ml. Concentrations of 8-isoprostane were also increased during the exacerbation (13.0 (0.9) pg/ml) and fell after antibiotic treatment to 9.0 (0.6) pg/ml (p<0.0001). In 12 patients there was a further fall from 9.3 (0.7) pg/ml to 6.0 (0.7) pg/ml (p<0.001) after 2 months compared with normal subjects (6.2 (0.4) pg/ml).
CONCLUSIONS: Non-invasive markers of inflammation and oxidative stress are increased during an infective exacerbation of COPD and only slowly recover after treatment with antibiotics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668789      PMCID: PMC1746632          DOI: 10.1136/thorax.58.4.294

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  32 in total

1.  Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease.

Authors:  P Paredi; S A Kharitonov; D Leak; S Ward; D Cramer; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  2000-08       Impact factor: 21.405

2.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.

Authors:  A Bhowmik; T A Seemungal; R J Sapsford; J A Wedzicha
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

3.  Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis.

Authors:  A T Hill; E J Campbell; S L Hill; D L Bayley; R A Stockley
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

4.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

Authors:  T A Seemungal; G C Donaldson; A Bhowmik; D J Jeffries; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

5.  Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD.

Authors:  S G Adams; J Melo; M Luther; A Anzueto
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

6.  Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients.

Authors:  P Montuschi; M Corradi; G Ciabattoni; J Nightingale; S A Kharitonov; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

7.  Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers.

Authors:  P Montuschi; J V Collins; G Ciabattoni; N Lazzeri; M Corradi; S A Kharitonov; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

8.  Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.

Authors:  R A Stockley; C O'Brien; A Pye; S L Hill
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

9.  Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.

Authors:  S Gompertz; D L Bayley; S L Hill; R A Stockley
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

10.  Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease.

Authors:  M Roland; A Bhowmik; R J Sapsford; T A Seemungal; D J Jeffries; T D Warner; J A Wedzicha
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

View more
  53 in total

Review 1.  Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease?

Authors:  C M Harrison; C C Andersen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

2.  Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis.

Authors:  Hannele Lehtonen; Panu Oksa; Lauri Lehtimäki; Anna Sepponen; Riina Nieminen; Hannu Kankaanranta; Seppo Saarelainen; Ritva Järvenpää; Jukka Uitti; Eeva Moilanen
Journal:  Thorax       Date:  2007-01-24       Impact factor: 9.139

3.  Expression of 5-lipoxygenase in specialized epithelial cells of nasopharyngeal-associated lymphoid tissue.

Authors:  Thomas G Brock
Journal:  J Mol Histol       Date:  2006-04-28       Impact factor: 2.611

Review 4.  The Effectiveness of Anti-leukotriene Agents in Patients with COPD: A Systemic Review and Meta-analysis.

Authors:  Jong Hoo Lee; Hyun Jung Kim; Yee Hyung Kim
Journal:  Lung       Date:  2015-05-14       Impact factor: 2.584

Review 5.  Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease: a critical review of the literature.

Authors:  Ho Il Yoon; Don D Sin
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

6.  Determining urea levels in exhaled breath condensate with minimal preparation steps and classic LC-MS.

Authors:  Masha Pitiranggon; Matthew S Perzanowski; Patrick L Kinney; Dongqun Xu; Steven N Chillrud; Beizhan Yan
Journal:  J Chromatogr Sci       Date:  2013-11-04       Impact factor: 1.618

Review 7.  Cough and its importance in COPD.

Authors:  Jaclyn Smith; Ashley Woodcock
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

8.  Comparative analysis of selected exhaled breath biomarkers obtained with two different temperature-controlled devices.

Authors:  Frank Hoffmeyer; Monika Raulf-Heimsoth; Volker Harth; Jürgen Bünger; Thomas Brüning
Journal:  BMC Pulm Med       Date:  2009-11-30       Impact factor: 3.317

Review 9.  Clinical use of exhaled biomarkers in COPD.

Authors:  Philip O'Reilly; William Bailey
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

10.  COPD exacerbation: lost in translation.

Authors:  Demosthenes Makris; Demosthenes Bouros
Journal:  BMC Pulm Med       Date:  2009-01-29       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.